Korea's NAMs Regulatory Development
South Korea is rapidly developing its NAMs regulatory framework, driven by a strong domestic organ-on-chip industry and government support for innovative pharmaceutical technologies.
KoVAM Validation Center
The Korean Center for the Validation of Alternative Methods (KoVAM) validates NAMs against OECD test guidelines and develops Korea-specific acceptance criteria.
- OECD Alignment: Validates NAMs against international standards
- Industry Support: Assists companies in NAMs validation
- International Cooperation: Partners with ICCVAM, JaCVAM, EURL-ECVAM